Alector (ALEC) Liabilities and Shareholders Equity (2018 - 2026)

Alector (ALEC) posted quarterly Liabilities and Shareholders Equity of $239.9 million for Q1 2026, down 41.24% year-over-year from $408.3 million in Q1 2025, and down 18.18% quarter-over-quarter from $293.2 million in Q4 2025.

Alector (ALEC) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Liabilities and Shareholders Equity for 9 consecutive years, with $239.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 41.24% year-over-year to $239.9 million; the TTM figure through Mar 2026 stood at $1.2 billion (down 37.61% YoY), while the FY2025 annual figure was $293.2 million, down 37.38% from the prior year.
  • Liabilities and Shareholders Equity fell to $239.9 million in Q1 2026 per ALEC's latest filing, from $293.2 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $954.5 million in Q1 2022 and bottomed at $239.9 million in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $590.8 million across 5 years, with a median of $621.8 million in 2023.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 124.03% — and 2026, when it plunged 41.24%.
  • Alector's Liabilities and Shareholders Equity stood at $787.6 million in 2022, then fell by 21.05% to $621.8 million in 2023, then slipped by 24.69% to $468.3 million in 2024, then slumped by 37.38% to $293.2 million in 2025, then slipped by 18.18% to $239.9 million in 2026.
  • Business Quant data shows ALEC's Liabilities and Shareholders Equity at $239.9 million in Q1 2026, $293.2 million in Q4 2025, and $335.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 10.03 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 4.32 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 9.18 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 15.59 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.82 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 5.56 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 2.10 Bn
10 Alector 218.85 Mn 46.05 Mn - 202.86 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 202.86 Mn
Mar 31, 2026 239.92 Mn
Dec 31, 2025 293.24 Mn
Sep 30, 2025 335.29 Mn
Jun 30, 2025 356.42 Mn
Mar 31, 2025 408.30 Mn
Dec 31, 2024 468.30 Mn
Sep 30, 2024 516.02 Mn
Jun 30, 2024 570.73 Mn
Mar 31, 2024 635.49 Mn
Dec 31, 2023 621.83 Mn
Sep 30, 2023 672.40 Mn
Jun 30, 2023 708.74 Mn
Mar 31, 2023 748.34 Mn
Dec 31, 2022 787.65 Mn
Sep 30, 2022 837.04 Mn
Jun 30, 2022 889.67 Mn
Mar 31, 2022 954.46 Mn
Dec 31, 2021 814.66 Mn
Sep 30, 2021 854.23 Mn